Distributed Healthcare is clinically governed by the American Healthcare Quality Board (AHQB), an Expert Board with reimbursement-schedule authority, safe-harbor practice guidelines, and quality-monitoring intervention powers. The Healthcare Cost Brake macrogovernor enforces cost discipline within statutory bounds. Anti-cream-skimming architecture explicitly prevents provider, patient, and geographic inequities. Pharmaceutical pricing references international comparators.
The architecture explicitly addresses three cream-skimming risks: provider cream-skimming (preferring healthy patients or high-margin regions), patient cream-skimming (Tier-4 supplemental targeting healthy populations or excluding high-cost ones), and geographic inequity (provider participation patterns concentrating in high-margin regions while underserved areas atrophy). Reimbursement is set centrally by AHQB on objective indices; geographic adjustments are formulaic; underserved areas receive enhanced reimbursement; supplemental coverage is guaranteed-issue + community-rated with statutory prohibition on cream-skimming product design.
Cream-skimming is the most-cited attack vector against universal coverage proposals. The architecture's response is explicit, defensible, and structurally enforceable.
Universal-coverage architectures fail at cream-skimming when they're not explicitly designed to prevent it. The historical pattern: a universal floor is enacted; private supplemental tiers emerge; supplemental insurers compete on price by selectively enrolling healthy populations; the floor's risk pool concentrates the high-cost population; floor coverage quality erodes as cost pressure mounts; the political constituency for floor improvement weakens because most of the politically-active middle class has migrated to supplemental.
This is not hypothetical. Variants of this pattern have produced quality erosion in Australia (where private hospital insurance has produced two-tier delivery in some specialties), Germany (where private substitutive insurance is restricted but parallel still produces cream-skimming pressure), and historically the UK's NHS (where pay-beds and consultant private practice produced two-tier dynamics until reforms tightened the boundaries).
The Accord's Distributed Healthcare architecture is designed from the outset to prevent the failure mode. Three structural mechanisms: central reimbursement-setting by AHQB (no provider negotiation); guaranteed-issue + community-rating on supplemental (no risk-rating, no exclusion of high-cost populations); enhanced reimbursement for underserved areas (positive incentive for provider participation in low-margin regions). All three are statutory and AHQB-enforced.
Three categories of cream-skimming prevention, each with distinct mechanisms.
Provider cream-skimming prevention: AHQB sets reimbursement schedules centrally, not negotiated locally. Geographic adjustments use objective indices: BLS regional CPI for cost-of-living, county wage data for labor costs, RUCA codes for rurality and underserved-area designation. Equity floor: facilities serving low-income or rural populations receive enhanced reimbursement, not reduced. AHQB monitors provider participation patterns; if provider organizations cluster their participation in high-margin regions and avoid underserved areas, AHQB has intervention authority — including direct federal operation through VHA expansion or hospital takeover, and Kaiser-style RFI/RFQ contracts that require statewide or multi-region service commitments.
Patient cream-skimming prevention: Tier-4 supplemental is offered on guaranteed-issue terms with community rating. No medical underwriting. No pre-existing condition exclusions. Premium variation only by age and geography, within statutory bands (band specifications pending v10.2). Prohibition on Tier-4 marketing that targets healthy populations or excludes high-cost ones. AHQB monitors enrollment patterns; plans with anomalous enrollment patterns face audit and regulatory action. Plan designs are subject to AHQB approval before market launch — designs that would produce cream-skimming patterns are denied approval.
Geographic equity: cost-of-living adjustment uses objective indices, not provider negotiation. Regional reimbursement reflects actual cost of providing care, not market power of providers. Underserved areas (rural, low-income urban, frontier) receive enhanced reimbursement to attract and retain providers. The architecture explicitly funds rural maternity care, rural emergency services, and frontier-community delivery at rates above the strict cost-of-living index would produce — recognizing that low-volume operations in underserved areas have structural costs that flat reimbursement does not capture.
- AHQB
- Cream-skimming prevention is a primary AHQB authority. Monitoring + intervention + product approval all flow through AHQB.
- Payment design
- Capacity-payment vs. fee-for-service decisions are made centrally; reimbursement schedules are AHQB-set on objective indices.
- Supplemental tier
- Supplemental product approval, marketing rules, and pricing rules are core anti-cream-skimming surfaces.
- VHA expansion
- Direct federal operation via VHA is an anti-cream-skimming backstop where private/contracted providers under-serve a region.
- Hospital takeovers
- Federal acquisition of distressed rural hospitals prevents the geographic-inequity failure mode by design.
- Central reimbursement-setting
- AHQB sets reimbursement schedules; no per-provider negotiation. Removes the lever providers use to reward selective patient acceptance.
- Geographic indices
- BLS regional CPI + county wage data + RUCA codes. Objective methodology; not subject to provider lobbying.
- Underserved-area uplift
- Rural, frontier, low-income urban areas receive enhanced reimbursement. Positive incentive for provider participation, not a punishment for high-margin regions.
- Provider monitoring
- AHQB tracks participation patterns. Cream-skimming clusters trigger intervention: federal direct operation, hospital takeover, or RFI/RFQ contract restructure.
- Guaranteed issue (supplemental)
- All applicants accepted. No exclusions for pre-existing conditions, ever. No occupation-based or behavior-based variation.
- Community rating
- Premium variation by age and geography only, within statutory bands. No individual risk-rating.
- Marketing prohibition
- Plans cannot target healthy populations or exclude high-cost ones. Benefit designs that effectively cream-skim by category fail AHQB approval.
- Pre-launch product approval
- Tier-4 product designs subject to AHQB review. Designs producing cream-skimming patterns are denied approval before reaching market.
- Enrollment-pattern monitoring
- AHQB monitors actual enrollment for emergent cream-skimming. Plans with anomalous patterns face audit + regulatory action.
Cream-skimming is a quality-degradation risk: when a universal architecture is undermined by selective enrollment, the floor's clinical quality typically degrades over time as the risk pool concentrates the high-cost, complex-care population. AHQB's anti-cream-skimming authorities are quality-safety mechanisms as well as equity mechanisms — they protect the floor's clinical-quality trajectory by preventing the risk-pool concentration that drives quality erosion.
The architecture's commitment is monitorable. AHQB publishes provider-participation patterns by geography and demographic. AHQB publishes Tier-4 enrollment patterns by health status. Anomalies are flagged publicly; intervention is documented. Sunlight on cream-skimming patterns is itself a deterrent.
Provider organizations face a different incentive structure than under current US healthcare. Today, profitable patients and profitable regions are systematically preferred; the architecture flips that by making underserved-area participation positive-margin (via enhanced reimbursement) and selective-enrollment unprofitable (via central rate-setting). Provider organizations that built business models around cream-skimming face a real adjustment.
Most clinicians experience the change as positive: less administrative work around payer-mix optimization, less pressure to selectively schedule high-margin patients, more autonomy in clinical decision-making. The architecture's commitment is that clinicians serve patients on clinical criteria, not on reimbursement-margin criteria.
Patients experience cream-skimming prevention indirectly: they don't face provider refusal of care based on insurance status (Distributed Healthcare floor coverage is universal); they don't face Tier-4 supplemental discrimination based on health history (guaranteed-issue applies); they receive equivalent care regardless of geography (enhanced reimbursement supports rural and underserved-area delivery).
The architecture's commitment is invisible to most patients in normal operation. The patient who has always had good employer coverage doesn't notice that supplemental is guaranteed-issue, because they were always going to be accepted. The patient with a chronic condition does notice — they have access to supplemental coverage they would have been denied or premium-loaded for under current US private insurance. The patient in a rural area notices that primary care + emergency services remain available, because enhanced reimbursement keeps providers in their region.
Cream-skimming prevention is administratively heroic. Real-world implementation will face provider gaming (selective scheduling, soft refusals dressed as scheduling unavailability), supplemental-product gaming (benefit designs that nominally meet rules but effectively segment risk), and political pressure from provider organizations to relax monitoring. The architecture's commitment is good but operational reality typically erodes such commitments over time.
The architecture's anti-cream-skimming surface is broader than current US tools, but the operational lift is precedented. Medicare Part C plans are subject to risk-adjustment and selective-enrollment monitoring under the existing CMS framework; the framework is imperfect but operational. Australia's anti-cream-skimming rules for private health insurance provide a comparable international precedent. The Accord's framework builds on these precedents with stronger statutory authority and broader monitoring scope.
The political-pressure concern is real and acknowledged. The architecture's response is structural: AHQB is an Expert Board (not an executive-branch agency subject to administration-by-administration political control), and its monitoring outputs are published publicly. Provider organizations that pressure AHQB face transparency about their pressure; the political cost of overt cream-skimming advocacy is real.
The product-gaming concern is the most architecturally important. The pre-launch product-approval mechanism is the architecture's primary defense — designs that would produce cream-skimming are stopped before market launch, not corrected after the fact. The architecture pairs prevention (pre-launch approval) with detection (enrollment-pattern monitoring) so that if novel gaming emerges, AHQB has both retrospective and prospective tools. The architecture does not assume the framework is perfect; it assumes it is iteratively improvable, which is honest.
Honesty about gaps. Distributed Healthcare has more unresolved specification than other Engines because operational complexity is higher; the items below are flagged for v10.2 specification or for outside expert review.
- Statutory band specifications for community rating: exact age-band and geography-band ratios pending v10.2.
- Underserved-area enhanced-reimbursement levels: the specific dollar uplift over base reimbursement for RUCA-coded underserved areas is pending v10.2 specification.
- Provider-participation pattern thresholds: the specific clustering metrics that trigger AHQB intervention are pending; today's CMS provider-participation monitoring is one starting point.
- Supplemental product-design approval process: the specific AHQB methodology for evaluating product designs against cream-skimming risk is pending v10.2.